Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
Pre-eclampsia is a disease that causes high blood pressure in 20th wee...Researchers in Canada may have discovered this simple blood test. ...He further said: This allows us to be more vigilant and see the w...Pre-eclampsia kills over 20'000 expectant mothers worldwide every ...Currently there is no test available. This allows us to be more v...
Pre-eclampsia is a disease that causes high blood pressure in 20th week// of Pregnancy and is a major cause of death of mother and infant in the world. Now a simple test that measures HLA-G levels in blood can predict women who are likely to develop the problem.
Researchers in Canada may have discovered this simple blood test. "We're really excited about this finding," said Clifford Librach, a researcher from Sunnybrook and Women's College Health Sciences Centre. In Toronto "I think it's really an advance in this area and something we hope will prevent this disease."
He further said: "This allows us to be more vigilant and see the woman more often and pick up the problem early enough that it doesn't become a more serious problem for mother and baby."
Pre-eclampsia kills over 20'000 expectant mothers worldwide every year. Pre-eclampsia is unpredictable and can appear suddenly in about one in 12 pregnancies. The blood pressure shoots up in the mothers-to-be and can cause seizures or fits, stroke and kidney related complications. This can result in stillbirth or fetal distress. The condition accounts for more than 15% of all premature births.
Currently there is no test available. "This allows us to be more vigilant and see the woman more often and pick up the problem early enough that it doesn't become a more serious problem for mom and baby," said Librach.
Scientists now believe that they have tracked down the cause of the disease and found this to be a molecule secreted by the placenta. The molecule is called ‘HLA-G molecule ‘ and is a protective substance that helps in preventing the mother's body to reject the unborn child.
Prof Shennan, a Professor of obstetrics at Guy's and St Thomas' hospital in London, added: "This is an important development because it helps to identify which part of the immune system is involved in pre-eclampsia. We've always known that immunology has been important and '"/>
(Date:11/8/2009)...re-USNewswire/ -- The American Public Health Assoc... provisions in the health reform bill passed last ...ll, the House takes important steps toward univers...s and moving our health system from one that focus...ping people healthy," said Georges C. Benjamin, MD...
(Date:11/8/2009)...s Nail Nation,s Job Creators ,, WASHINGTON, Nov... House passage of the health care bill (H.R. 3962)...BE Council) president & CEO Karen Kerrigan iss...ke, those voting for H.R. 3962 voted to burden our...ing taxes and penalties. Even in the best of econo...
(Date:11/8/2009)...ing of biopharmaceuticals to be available at the C... Toronto, ON (PRWEB) Novemb... Therapure Biopharma Inc. today announced that the...pharmaceutical grade freeze dryer and expects to m...) available for contract manufacturing of biopharm...
(Date:11/8/2009)...ispanic health advocates committed to achieving me...TON, Nov. 7 "Tonight th...eard the voice of America,s families by passing th...Senate must deliver, without delay, on the promise...L. Delgado, President and CEO of the National Alli...
(Date:11/8/2009)... Health Care Reform Bill ,, Critical legislat...r all Americans ,, CHICAGO, Nov. 7 /PRNewswire...Representatives passed by a vote of 220-215, criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,,...
...Va., May 16 CEL-SCI CORPORATION,(Amex: CVM ) rep...s ended,March 31, 2008., Geert Kersten, Chief Exe...e completely focused on getting our cancer therapy...ng facility for,Multikine from which we can supply...
... Clinical Functionality and Innovative Clinical To...formance, LAS VEGAS, May 16 Vital Images, Inc. (...de advanced visualization and,analysis solutions f...th Annual Workstation Face-Off, highlighted,the br...
...ILL, N.C., May 16 Superior launch strategies,allo... as a leader in,crowded markets. To secure "share ...elop specific uptake strategies to support busines...oduct,s,success., "Best Practices for Winning Pro...
... to Visit Omaha to Rally Residents to Eat Right, M...ir Diets, OMAHA, Neb., May 16 The last decade ca... diets -- which seem to go in and out of,fashion l...in overweight or obese., A new campaign crossing ...
...e expands natural killer cells in cord blood more ... News) A treatment that uses natural killer (NK) ...ctively destroys human leukemia cells in mice, res... test mice with aggressive human leukemias, accord...
... following news tips are based on abstracts or pos...rican Society of Clinical Oncology (ASCO) to be he... Study Tracks a Biomarker for Early Detection of ... NYU Cancer Institutes Harvey Pass, M.D., professo...
(Date:11/6/2009)...ov. 6 America,s Special... group of mid-market and smaller innovator pharmac...H.R. 3962, the "Affordable Health Care for America.... These smaller companies fear that the cumulativ... hinder their efforts to bring new medicines to ma...
(Date:11/6/2009)...ss., Nov. 6 Facet Solutions, Inc. ...sets of Archus Orthopedics. The acquisition create...erings, intellectual property and clinical experie...in for patients suffering from lumbar spinal steno... Geoff Pardo. "This consolidation further strengt...
(Date:11/6/2009)..., Nov. 6 Boston Scientif...it has reached an agreement in principle with the ...t advisories issued by its Guidant subsidiary in 2...ed prior to Boston Scientific,s 2006 acquisition o...disclosed an investigation by the U.S. Attorney,s ...
...uticals, Inc. (Nasdaq: IDIX ), a biopharmaceutic...t of drugs for the treatment of human viral and ot...as initiated a proof-of-concept study of IDX184, a...he treatment of HCV under an Investigational New D...Administration (FDA). The study is evaluating IDX1...
...-B(R) for lupus and ABthrax(R) for inhalation anth...on - , , - GSK Phase 3 trial of darapladib underw...provides 2009 financial guidance; expects less tha... Jan. 12 Human Genome Sciences, Inc. (Nasdaq: H...d report on the Company,s progress toward commerci...